Antimicrobiens

Inhibitor of cell wall biogenesis; glycopeptide antibiotic

Anti-fungal; glucan synthase inhibitor

Non-nucleoside reverse transcriptase inhibitor; antiviral agent against HIV

Inhibitor of DNA replication; aminoglycoside class

Inhibitor of hepatitis C viral enzyme NS3-4A serine protease

N-Boc-protected -Guanidino Oseltamivir is a fine chemical that belongs to the group of versatile building blocks. It is a complex compound that has been used in research as a reagent and speciality chemical. N-Boc-protected -Guanidino Oseltamivir is an important intermediate for the synthesis of a variety of useful compounds, such as pharmaceuticals and natural products. This compound is also used as a reaction component in organic syntheses, especially for the preparation of high quality and useful scaffolds.

Tenofovir is an acyclic nucleoside phosphonate that exhibits anti-viral properties through its inhibition of reverse transcriptases. In particular, Tenofovir is a potent inhibitor of Human Immunodeficiency Virus (HIV) and chronic Hepatitis B Virus (HBV) reverse transcriptases, thus preventing the replication of genetic viral material. This property is beneficial in virus research areas and developing antiviral treatments. Once inside the body tenofovir is metabolized into its active form, tenofovir diphosphate, by the lysosomal protease cathepsin A, nucleotide kinases and adenylate kinases. 
Tenofovir is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Ritonavir is a HIV protease inhibitor. It has an anti-retroviral activity as it inhibits the protease enzymes specific of both HIV-1 and HIV-2 and has been shown to be effective in controlling virus replication in humans and animals. Ritonavir works by preventing the HIV viral protease enzyme from cleaving the structural and replicative proteins produced by HIV genes such as gag and pol.

Exalamide is an arenecarboxamide antifungal agent with action on fungal growth inhibition and is used for research on fungal infections.

Avermectin B1a (>85%) is a macrolide anthelmintic and is used for the treatment of parasitic infections. It enhances the effects of glutamate at the glutamate-gated chloride channels, causing paralysis and death of the parasite

Geneticin is very efficient against gram-negative bacteria, however it is not applied for treating infections due to high renal toxicity. Geneticin and its resistance genes found application in the selection of transgenic cell lines including yeasts such as P. pastoris and S. serevisiae, other eukaryotic cell lines such as CHO or HEK293, but also plant cells and bacterial cells.

Inhibitor of DNA replication; inhibitor of theophylline and caffeine metabolism

Anti-viral; inhibits Hepatitis C virus NS3/4a protease

Moxalactam Sodium Salt (Mixture of diastereomers) is an oxacephem antibiotic with action on bacterial cell wall synthesis and is used for treating infections caused by gram-negative bacteria like Escherichia coli and Pseudomonas aeruginosa

Tilmicosin is a macrolide antibiotic that is used in veterinary medicine. It is used to treat bovine respiratory disease and inhibits bacterial growth by binding to the 50S ribosomal subunit of the bacteria resulting in reduced protein synthesis.

Saquinavir is a HIV protease inhibitor drug that is used with other antiretroviral drugs for the treatment of HIV-1. As this drug prevents HIV protease activity, it prevents the proteolysis of the Gag polyprotein and thus results in non-infectious virus particles.

Darunavir is a HIV-1 protease inhibitor used orally in the treatment of patients with multi-drug resistant HIV-1 infection (Ghosh, 2007). It has also been shown to be effective against other infectious diseases such as hepatitis C virus and SARS coronavirus. Metabolized by cytochrome P450 3A (CYP3A) isoenzymes, darunavir is often administered together with ritonavir that prolongs its bioavaiability, giving a terminal elimination half-life (t1/2) of 15 hours (Back, 2008). The effect of darunavir on natural compounds such as matrix proteins and toll-like receptor activity has also been studied via high performance liquid chromatography (HPLC) experiments.